跳至主要内容
临床试验/NCT05189873
NCT05189873已完成3 期

Comparison of the Pregnancy Outcomes in Patients With the Polycystic Ovarian Syndrome in Two Endometrial Preparation Method GnRH Agonist Plus Hormone Replacement Therapy Versus Hormone Replacement Therapy in Frozen Embryo Transfer Cycle

Tehran University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2021年6月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
128
试验地点
1
主要终点
Chemical pregnancy

研究概览

简要总结

The study is conducted at Arash Women's Hospital on all women undergoing the frozen embryo transfer cycle. Patients who signed informed consent will be randomly divided into two groups. The first group will receive GnRH agonist plus hormone replacement therapy for endometrial preparation. Group 2 will receive hormone replacement therapy. The random allocation and final outcome of the study will be assessed by a person who is unaware of the study process. Also, the statistician will be unaware of the study process

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

盲法说明

The randomization list will be prepared by a statistician using the block randomization method (using the site:www.sealedenvelope.com). Treatments are placed in sealed envelopes and will be kept by the out-of-study nurse. After identification of the eligibility of the patient, the procedure is explained to her and informed consent is obtained. Then the treatment is performed based on the kind of treatment in the envelope.

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • The first or second cycle of embryo transfer Normal uterine cavity PCO diagnosis based on Rotterdam criteria and correction (2018) Age 20 to 40 years

排除标准

  • Infertility with severe male factor endometriosis immunological disease FSH higher than 10 BMI greater than or equal to 30 Endometrial thickness on the day of transfer is less than 7 mm History of recurrent miscarriage

研究组 & 干预措施

HRT

Experimental

HRT protocol : estradiol and progesterone

干预措施: HRT (Drug)

Long GnRH agonist + HRT

Experimental

Long GnRH agonist + HRT protocol: Superfect and estradiol and progesterone

干预措施: Long GnRH agonist + HRT (Drug)

结局指标

主要结局

Chemical pregnancy

时间窗: 14 days after transfer

A positive beta hCG levels

Clinical pregnancy

时间窗: 12 weeks of pregnancy

The gestational sac will be observed by Ultrasonography

Endometrial thickness

时间窗: On the day of transfer

Endometrial thickness on the day of transfer will be measured by transvaginal ultrasound

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验